117 related articles for article (PubMed ID: 12324571)
1. Quantitative analysis of thymosin beta-10 messenger RNA in thyroid carcinomas.
Takano T; Hasegawa Y; Miyauchi A; Matsuzuka F; Yoshida H; Kuma K; Amino N
Jpn J Clin Oncol; 2002 Jul; 32(7):229-32. PubMed ID: 12324571
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of kalpha1 tubulin mRNA in thyroid anaplastic carcinoma.
Takano T; Hasegawa Y; Miyauchi A; Matsuzuka F; Yoshida H; Kuma K; Amino N
Cancer Lett; 2001 Jul; 168(1):51-5. PubMed ID: 11368877
[TBL] [Abstract][Full Text] [Related]
3. Quantitative measurement of telomerase reverse transcriptase, thyroglobulin and thyroid transcription factor 1 mRNAs in anaplastic thyroid carcinoma tissues and cell lines.
Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
Oncol Rep; 2007 Sep; 18(3):715-20. PubMed ID: 17671725
[TBL] [Abstract][Full Text] [Related]
4. Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA.
Takano T; Miyauchi A; Yokozawa T; Matsuzuka F; Maeda I; Kuma K; Amino N
Cancer Res; 1999 Sep; 59(18):4542-5. PubMed ID: 10493503
[TBL] [Abstract][Full Text] [Related]
5. Thymosin beta-10 gene overexpression correlated with the highly malignant neoplastic phenotype of transformed thyroid cells in vivo and in vitro.
Califano D; Monaco C; Santelli G; Giuliano A; Veronese ML; Berlingieri MT; de Franciscis V; Berger N; Trapasso F; Santoro M; Viglietto G; Fusco A
Cancer Res; 1998 Feb; 58(4):823-8. PubMed ID: 9485041
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of glutathione peroxidase mRNA in thyroid anaplastic carcinoma.
Hasegawa Y; Takano T; Miyauchi A; Matsuzuka F; Yoshida H; Kuma K; Amino N
Cancer Lett; 2002 Aug; 182(1):69-74. PubMed ID: 12175525
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in normal and malignant thyroid tissues by real-time polymerase chain reaction.
Egawa C; Miyoshi Y; Iwao K; Shiba E; Noguchi S
Oncology; 2001; 61(4):293-8. PubMed ID: 11721176
[TBL] [Abstract][Full Text] [Related]
8. Measurement of the expression of oncofetal fibronectin mRNA in thyroid carcinomas by competitive reverse transcription-polymerase chain reaction.
Higashiyama T; Takano T; Matsuzuka F; Liu G; Miyauchi A; Yokozawa T; Morita S; Kuma K; Shiba E; Noguchi S; Amino N
Thyroid; 1999 Mar; 9(3):235-40. PubMed ID: 10211598
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of osteonectin mRNA in thyroid carcinomas.
Takano T; Hasegawa Y; Miyauchi A; Matsuzuka F; Yoshida H; Kuma K; Hayashi N; Nakamori S; Amino N
Endocr J; 2002 Aug; 49(4):511-6. PubMed ID: 12402984
[TBL] [Abstract][Full Text] [Related]
10. Rapid screening of specific changes in mRNA in thyroid carcinomas by sequence specific-differential display: decreased expression of acid ceramidase mRNA in malignant and benign thyroid tumors.
Maeda I; Takano T; Matsuzuka F; Maruyama T; Higashiyama T; Liu G; Kuma K; Amino N
Int J Cancer; 1999 May; 81(5):700-4. PubMed ID: 10328219
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target.
Magro G; Cataldo I; Amico P; Torrisi A; Vecchio GM; Parenti R; Asioli S; Recupero D; D'Agata V; Mucignat MT; Perris R
Thyroid; 2011 Mar; 21(3):267-77. PubMed ID: 21323588
[TBL] [Abstract][Full Text] [Related]
12. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK
J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens.
Giannini R; Faviana P; Cavinato T; Elisei R; Pacini F; Berti P; Fontanini G; Ugolini C; Camacci T; De Ieso K; Miccoli P; Pinchera A; Basolo F
Thyroid; 2003 Aug; 13(8):765-70. PubMed ID: 14558920
[TBL] [Abstract][Full Text] [Related]
14. Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms.
Fabbro D; Di Loreto C; Beltrami CA; Belfiore A; Di Lauro R; Damante G
Cancer Res; 1994 Sep; 54(17):4744-9. PubMed ID: 8062273
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of catalase mRNA in thyroid anaplastic carcinoma.
Hasegawa Y; Takano T; Miyauchi A; Matsuzuka F; Yoshida H; Kuma K; Amino N
Jpn J Clin Oncol; 2003 Jan; 33(1):6-9. PubMed ID: 12604716
[TBL] [Abstract][Full Text] [Related]
16. Expression of thyrotrophin receptor gene in thyroid carcinoma is associated with a good prognosis.
Shi Y; Zou M; Farid NR
Clin Endocrinol (Oxf); 1993 Sep; 39(3):269-74. PubMed ID: 8222289
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of a heterogeneous transcription pattern of thyroglobulin mRNA in human thyroid tissues.
Bertaux F; Noel M; Malthiéry Y; Fragu P
Biochem Biophys Res Commun; 1991 Jul; 178(2):586-92. PubMed ID: 1859419
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiles in thyroid carcinomas.
Takano T; Hasegawa Y; Matsuzuka F; Miyauchi A; Yoshida H; Higashiyama T; Kuma K; Amino N
Br J Cancer; 2000 Dec; 83(11):1495-502. PubMed ID: 11076659
[TBL] [Abstract][Full Text] [Related]
19. Thymosin beta-10 gene expression as a possible tool in diagnosis of thyroid neoplasias.
Chiappetta G; Pentimalli F; Monaco M; Fedele M; Pasquinelli R; Pierantoni GM; Ribecco MT; Santelli G; Califano D; Pezzullo L; Fusco A
Oncol Rep; 2004 Aug; 12(2):239-43. PubMed ID: 15254683
[TBL] [Abstract][Full Text] [Related]
20. Gene expression of differentiation- and dedifferentiation markers in normal and malignant human thyroid tissues.
Hoang-Vu C; Dralle H; Scheumann G; Maenhaut C; Horn R; von zur Mühlen A; Brabant G
Exp Clin Endocrinol; 1992; 100(1-2):51-6. PubMed ID: 1281780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
